<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN">
<html xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /><title>DT-IMMZ.D5.DT.DTPcontraindications</title><link rel="stylesheet" type="text/css" href="includes/dmn.css" /></head><body><table xmlns="" class="decision"><tr class="decision-header"><td class="row-label">Decision ID</td><td colspan="100"><span class="decision-id">DT-IMMZ.D5.DT.DTPcontraindications</span><span class="decision-name">DT-IMMZ.D5.DT.DTPcontraindications</span></td></tr><tr class="io-row"><td class="row-label">Inputs/Outputs</td><td class="input">Potential contraindications</td></tr><tr class="rule"><td class="row-label"></td><td class="inputEntry">
          "Potential contraindications" = "History of anaphylactic reactions"
          The client has a history of anaphylactic reactions
        </td><td class="outputEntry">
          "Immunization recommendation status" = "Further evaluation needed" (where "Vaccine type" = "Pertussis-containing vaccines")
AND 
"Immunization recommendation status" = "Further evaluation needed" (where "Vaccine type" = "Tetanus-containing vaccines")
          Tetanus and pertussis vaccination could be contraindicated. Clinical judgement is required. Create a clinical note
        </td><td class="outputEntry">
          Do not vaccinate client with pertussis and/or tetanus if the client has had a severe anaphylactic reaction to a vaccine component or reaction following a prior dose.
          Do not vaccinate client with pertussis and/or tetanus if the client has had a severe anaphylactic reaction to a vaccine component or reaction following a prior dose.
        </td><td class="annotationEntry">
          Tetanus: A severe anaphylactic reaction to a vaccine component or following a prior dose of tetanus-containing vaccines is a contraindication to receive tetanus-containing vaccines.

Pertussis: Except in those who have experienced a rare anaphylactic reaction following administration of whole-cell pertussis (wP) or acellular pertussis (aP) vaccines, there are no contraindications for the use of these vaccines. 
        </td><td class="annotationEntry">
          Pertussis  vaccines: WHO position paper (August 2015) (6)
Tetanus vaccines: WHO position paper (February 2017) (7)
        </td><td class="annotationEntry">
          Tetanus: A severe anaphylactic reaction to a vaccine component or following a prior dose of tetanus-containing vaccines is a contraindication to receive tetanus-containing vaccines.

Pertussis: Except in those who have experienced a rare anaphylactic reaction following administration of whole-cell pertussis (wP) or acellular pertussis (aP) vaccines, there are no contraindications for the use of these vaccines. 
        </td><td class="annotationEntry">
          Pertussis  vaccines: WHO position paper (August 2015) (6)
Tetanus vaccines: WHO position paper (February 2017) (7)
        </td></tr><tr class="rule"><td class="row-label"></td><td class="inputEntry">
          "Potential contraindications" = "Severe acute illness"
          The client currently has a severe acute illness
        </td><td class="outputEntry">
          "Immunization recommendation status" = "Contraindicated" (where "Vaccine type" = "Tetanus -containing vaccines")
          Tetanus vaccination is contraindicated
        </td><td class="outputEntry">
          Do not vaccinate client with tetanus as tetanus vaccination is contraindicated for clients with severe acute illness
          Do not vaccinate client with tetanus as tetanus vaccination is contraindicated for clients with severe acute illness
        </td><td class="annotationEntry">
          A severe acute illness should lead to delaying vaccination, but a minor or moderate illness should not.
        </td><td class="annotationEntry">
          Tetanus vaccines: WHO position paper (February 2017) (7)
        </td><td class="annotationEntry">
          A severe acute illness should lead to delaying vaccination, but a minor or moderate illness should not.
        </td><td class="annotationEntry">
          Tetanus vaccines: WHO position paper (February 2017) (7)
        </td></tr></table></body></html>